Status epilepticus: Evidence and controversy

Neurologist

Volumn 13, Issue 6 SUPPL. 1, 2007, Pages

  Peñas, Juan José García ^a,b   Molins, Albert ^c   Puig, Javier Salas ^d  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Anticonvulsants; Epidemiology; Etiology; Sequelae; Status epilepticus

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BICARBONATE; CARBAMAZEPINE; CLOBAZAM; CLOMETHIAZOLE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; GABAPENTIN; ISOFLURANE; LIDOCAINE; LORAZEPAM; MANNITOL; MIDAZOLAM; OXCARBAZEPINE; PARALDEHYDE; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; PYRIDOXINE; THIAMINE; THIOPENTAL; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN;

AMBULATORY CARE; BRADYCARDIA; BRAIN SCINTISCANNING; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS; CONSENSUS; CONTINUOUS INFUSION; DISEASE CLASSIFICATION; DISEASE COURSE; EMERGENCY MEDICINE; EMERGENCY WARD; EPILEPTIC STATE; EVIDENCE BASED PRACTICE; FEBRILE CONVULSION; FOCAL EPILEPSY; HOMEOSTASIS; HOSPITAL CARE; HUMAN; HYPOTENSION; HYPOVENTILATION; LOADING DRUG DOSE; LUMBAR PUNCTURE; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RESPIRATION DEPRESSION; REVIEW; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT RESPONSE; VOMITING;

FEMALE; HUMANS; MALE; STATUS EPILEPTICUS;

EID: 37349033837     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e31815bb069     Document Type: Review

References (113)

1. Franklin GM, Zahn CA. AAN clinical practice guidelines: above the fray. Neurology. 2002;59:975-976.
2. Cook DJ, Greengold NL, Ellrodt AG, et al. The relation between systematic reviews and practice guidelines. Ann Intern Med. 1997;127:210-216.
3. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs. II. Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004;45:410-423.
4. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs. I. Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004;45:401-409.
5. Hixson JD, French JA. Guidelines for new antiepileptic drug evaluation. Rev Neurol Dis. 2004;1(suppl. 1):S18-S26.
6. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47:1094-1120.
7. Dodson. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA. 1993;270:854-859.
8. Shorvon S. The management of status epilepticus. J Neurol Neurosurg Psychiatry. 2001;70 (suppl. 2):II22-I127.
9. Brown JK, Hussain IH. Status epilepticus. I. Pathogenesis. Dev Med Child Neurol. 1991;33:3-17.
10. Proposal for classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. 1985;26:268-278.
11. Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia. 1999;40(suppl. 1):S3-S8; discussion S21-S22.
12. Shinnar S, Berg AT, Moshe SL, et al. How long do new-onset seizures in children last? Ann Neurol. 2001;49:659-664.
13. Fitzgerald BJ, Okos AJ, Miller JW. Treatment of out-of-hospital status epilepticus with diazepam rectal gel. Seizure. 2003;12:52-55.
14. Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol. 2004;11:800-810.
15. Lewena S, Young S. When benzodiazepines fail: how effective is second line therapy for status epilepticus in children? Emerg Med Australas. 2006;18:45-50.
16. Sahin M, Menache CC, Holmes GL, et al. Outcome of severe refractory status epilepticus in children. Epilepsia. 2001;42:1461-1467.
17. Goodkin HP, Yeh JL, Kapur J. Status epilepticus increases the intracellular accumulation of GABAA receptors. J Neurosci. 2005;25:5511-5520.
18. Naylor DE, Liu H, Wasterlain CG. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci. 2005;25:7724-7733.
19. Brown JK, Hussain IH. Status epilepticus. II. Treatment. Dev Med Child Neurol. 1991;33:97-109.
20. Wu YW, Shek DW, Garcia PA, et al. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology. 2002;58:1070-1076.
21. Riviello JJ Jr, Ashwal S, Hirtz D, et al. Practice parameter: diagnostic assessment of the child with status epilepticus (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2006;67:1542-1550.
22. Sillanpaa M, Shinnar S. Status epilepticus in a population-based cohort with childhood-onset epilepsy in Finland. Ann Neurol. 2002;52:303-310.
23. Berg AT, Shinnar S, Testa FM, et al. Status epilepticus after the initial diagnosis of epilepsy in children. Neurology. 2004;63:1027-1034.
24. Appleton R, Choonara I, Martland T, et al. The treatment of convulsive status epilepticus in children. The Status Epilepticus Working Party, Members of the Status Epilepticus Working Party. Arch Dis Child. 2000;83:415-419.
25. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029-1035.
26. Chin RF, Neville BG, Peckham C, et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006;368:222-229.
27. Hui AC, Joynt GM, Li H, et al. Status epilepticus in Hong Kong Chinese: aetiology, outcome and predictors of death and morbidity. Seizure. 2003;12:478-482.
28. Shinnar S, Pellock JM, Moshe SL, et al. In whom does status epilepticus occur: age-related differences in children. Epilepsia. 1997;38:907-914.
29. Asadi-Pooya AA, Poordast A. Etiologies and outcomes of status epilepticus in children. Epilepsy Behav. 2005;7:502-505.
30. Shinnar S, Maytal J, Krasnoff L, et al. Recurrent status epilepticus in children. Ann Neurol. 1992;31:598-604.
31. Knake S, Rosenow F, Vescovi M, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia. 2001;42:714-718.
32. Coeytaux A, Jallon P, Galobardes B, et al. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 2000;55:693-697.
33. Waterhouse EJ, DeLorenzo RJ. Status epilepticus in older patients: epidemiology and treatment options. Drugs Aging. 2001;18:133-142.
34. Bautista JF, Lüders HO. Semiological seizure classification: relevance to pediatric epilepsy. Epileptic Disord. 2000;2:65-72; discussion 73.
35. Lüders H, Acharya J, Baumgartner C, et al. Semiological seizure classification. Epilepsia. 1998;39:1006-1013.
36. Fountain NB. Status epilepticus: risk factors and complications. Epilepsia. 2000;41(suppl. 2):S23-S30.
37. Thomas P, Valton L, Genton P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain. 2006;129(Pt 5):1281-1292.
38. Garzon E, Fernandes RM, Sakamoto AC. Analysis of clinical characteristics and risk factors for mortality in human status epilepticus. Seizure. 2003;12:337-345.
39. KarasalIhoGlu S, Oner N, CeLtik C, et al. Risk factors of status epilepticus in children. Pediatr Int. 2003;45:429-434.
40. Chiron C, Bahi-Buisson N, Plouin P. [Treatment of status epilepticus in children with epilepsy]. Arch Pediatr. 2004;11:1217-1224.
41. Tassinari CA, Bureau-Paillas M, Grasso E, et al. [Electroencephalographic study of myoclonic cerebellar dyssynergia with epilepsy (Ramsay-Hunt syndrome)]. Rev Electroencephalogr Neurophysiol Clin. 1974;4:407-428.
42. Thomas P, Beaumanoir A, Genton P, et al. 'De novo' absence status of late onset: report of 11 cases. Neurology. 1992;42:104-110.
43. Tay SK, Hirsch LJ, Leary L, et al. Nonconvulsive status epilepticus in children: clinical and EEG characteristics. Epilepsia. 2006;47:1504-1509.
44. Meierkord H, Will B, Fish D, et al. The clinical features and prognosis of pseudoseizures diagnosed using video-EEG telemetry. Neurology. 1991;41:1643-1646.
45. Dworetzky BA, Mortati KA, Rossetti AO, et al. Clinical characteristics of psychogenic nonepileptic seizure status in the long-term monitoring unit. Epilepsy Behav. 2006;9:335-338.
46. Berg AT, Shinnar S. Complex febrile seizures. Epilepsia. 1996;37:126-133.
47. Scott RC, Gadian DG, King MD, et al. Magnetic resonance imaging findings within 5 days of status epilepticus in childhood. Brain. 2002;125(Pt 9):1951-1959.
48. Sokol DK, Demyer WE, Edwards-Brown M, et al. From swelling to sclerosis: acute change in mesial hippocampus after prolonged febrile seizure. Seizure. 2003;12:237-240.
49. Scott RC, King MD, Gadian DG, et al. Hippocampal abnormalities after prolonged febrile convulsion: a longitudinal MRI study. Brain. 2003;126(Pt 11):2551-2557.
50. Sagduyu A, Tarlaci S, Sirin H. Generalized tonic-clonic status epilepticus: causes, treatment, complications and predictors of case fatality. J Neurol. 1998;245:640-646.
51. Hirtz D, Ashwal S, Berg A, et al. Practice parameter: evaluating a first nonfebrile seizure in children: report of the quality standards subcommittee of the American Academy of Neurology, The Child Neurology Society, and The American Epilepsy Society. Neurology. 2000;55:616-623.
52. Hirtz D, Berg A, Bettis D, et al. Practice parameter: treatment of the child with a first unprovoked seizure: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2003;60:166-175.
53. Freeman JM. Less testing is needed in the emergency room after a first afebrile seizure. Pediatrics. 2003;111:194-196.
54. Sharma S, Riviello JJ, Harper MB, et al. The role of emergent neuroimaging in children with new-onset afebrile seizures. Pediatrics. 2003;111:1-5.
55. Cohen-Gadol AA, Britton JW, Worrell GA, et al. Transient cortical abnormalities on magnetic resonance imaging after status epilepticus: case report. Surg Neurol. 2004;61:479-482; discussion 482.
56. Cole AJ. Status epilepticus and periictal imaging. Epilepsia. 2004;45(suppl. 4):72-77.
57. Gilbert DL, Buncher CR. An EEG should not be obtained routinely after first unprovoked seizure in childhood. Neurology. 2000;54:635-641.
58. Treiman DM. Electroclinical features of status epilepticus. J Clin Neurophysiol. 1995;12:343-362.
59. Kutluay E, Beattie J, Passaro EA, et al. Diagnostic and localizing value of ictal SPECT in patients with nonconvulsive status epilepticus. Epilepsy Behav. 2005;6:212-217.
60. Garr RE, Appleton RE, Robson WJ, et al. Children presenting with convulsions (including status epilepticus) to a paediatric accident and emergency department: an audit of a treatment protocol. Dev Med Child Neurol. 1999;41:44-47.
61. Appleton R, Martland T, Phillips B. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev. 2002;(4):CD001905.
62. Chin RF, Verhulst L, Neville BG, et al. Inappropriate emergency management of status epilepticus in children contributes to need for intensive care. J Neurol Neurosurg Psychiatry. 2004;75:1584-1588.
63. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345:631-637.
64. Wermeling DP, Miller JL, Archer SM, et al. Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration. J Clin Pharmacol. 2001;41:1225-1231.
65. Melendez R, Batista D, Font D, et al. [Prolonged convulsions treated with buccal midazolam in a setting of mentally retarded patients with refractory epilepsy]. Neurologia. 2006;21:411-413.
66. Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet. 1999;353:623-626.
67. Harbord MG, Kyrkou NE, Kyrkou MR, et al. Use of intranasal midazolam to treat acute seizures in paediatric community settings. J Paediatr Child Health. 2004;40:556-558.
68. Mahmoudian T, Zadeh MM. Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children. Epilepsy Behav. 2004;5:253-255.
69. Lahat E, Goldman M, Barr J, et al. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ. 2000;321:83-86.
70. Brierley J. Danger of flumazenil use in pediatric status epilepticus. Pediatr Emerg Care. 2006;22:168-169.
71. Choudhery V, Townend W. Best evidence topic reports. Lorazepam or diazepam in paediatric status epilepticus. Emerg Med J. 2006;23:472-473.
72. Ozdemir D, Gulez P, Uran N, et al. Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus. Seizure. 2005;14:129-132.
73. Koul R, Chacko A, Javed H, et al. Eight-year study of childhood status epilepticus: midazolam infusion in management and outcome. J Child Neurol. 2002;17:908-910.
74. Wolfe TR, Macfarlane TC. Intranasal midazolam therapy for pediatric status epilepticus. Am J Emerg Med. 2006;24:343-346.
75. Kutlu NO, Dogrul M, Yakinci C, et al. Buccal midazolam for treatment of prolonged seizures in children. Brain Dev. 2003;25:275-278.
76. Wiznitzer M. Buccal midazolam for seizures. Lancet. 2005;366:182-183.
77. Scott RC. Buccal midazolam as rescue therapy for acute seizures. Lancet Neurol. 2005;4:592-593.
78. Galdames-Contreras D, Carrasco-Poblete E, Aguilera-Olivares L, et al. Intramuscular midazolam in the initial treatment of status epilepticus. Rev Neurol. 2006;42:332-335.
79. Lahat E, Aladjem M, Eshel G, et al. Midazolam in treatment of epileptic seizures. Pediatr Neurol. 1992;8:215-216.
80. Towne AR, DeLorenzo RJ. Use of intramuscular midazolam for status epilepticus. J Emerg Med. 1999;17:323-328.
81. Chamberlain JM, Altieri MA, Futterman C, et al. A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr Emerg Care. 1997;13:92-94.
82. Campistol J, Lopez J, Ruiz S. Estado del mal epiléptico en la infancia. Revisión casuística y protocolo de tratamiento. Rev Neurol. 1997;25(suppl. 4):S445-S451.
83. Touchette DR, Rhoney DH. Cost-minimization analysis of phenytoin and fosphenytoin in the emergency department. Pharmacotherapy. 2000;20:908-916.
84. Hodges BM, Mazur JE. Intravenous valproate in status epilepticus. Ann Pharmacother. 2001;35:1465-1470.
85. Uberall MA, Trollmann R, Wunsiedler U, et al. Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology. 2000;54:2188-2189.
86. Yamamoto LG, Yim GK. The role of intravenous valproic acid in status epilepticus. Pediatr Emerg Care. 2000;16:296-298.
87. Yu KT, Mills S, Thompson N, et al. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia. 2003;44:724-726.
88. Campistol J, Fernandez A, Ortega J. [Status epilepticus in children. Experience with intravenous valproate. Update of treatment guidelines]. Rev Neurol. 1999;29:359-365.
89. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology. 2006;67:340-342.
90. Lee WK, Liu KT, Young BW. Very-high-dose phenobarbital for childhood refractory status epilepticus. Pediatr Neurol. 2006;34:63-65.
91. Hamano S, Sugiyama N, Yamashita S, et al. Intravenous lidocaine for status epilepticus during childhood. Dev Med Child Neurol. 2006;48:220-222.
92. Pascual J, Ciudad J, Berciano J. Role of lidocaine (lignocaine) in managing status epilepticus. J Neurol Neurosurg Psychiatry. 1992;55:49-51.
93. Kim SJ, Lee DY, Kim JS. Neurologic outcomes of pediatric epileptic patients with pentobarbital coma. Pediatr Neurol. 2001;25:217-220.
94. Prasad A, Worrall BB, Bertram EH, et al. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia. 2001;42:380-386.
95. Schor NF, Riviello JJ Jr. Treatment with propofol: the new status quo for status epilepticus? Neurology. 2005;65:506-507.
96. van Gestel JP, Blusse van Oud-Alblas HJ, Malingre M, et al. Propofol and thiopental for refractory status epilepticus in children. Neurology. 2005;65:591-592.
97. Niermeijer JM, Uiterwaal CS, Van Donselaar CA. Propofol in status epilepticus: little evidence, many dangers? J Neurol. 2003;250:1237-1240.
98. Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol. 2004;61:1254-1259.
99. Mewasingh LD, Sekhara T, Aeby A, et al. Oral ketamine in paediatric non-convulsive status epilepticus. Seizure. 2003;12:483-489.
100. Hindley D, Hubber R, Martland T, et al. Audit of the use of chloral hydrate as an acute treatment for childhood seizures'. Dev Med Child Neurol. 2005;47:212-213.
101. Kahriman M, Minecan D, Kutluay E, et al. Efficacy of topiramate in children with refractory status epilepticus. Epilepsia. 2003;44:1353-1356.
102. Perry MS, Holt PJ, Sladky JT. Topiramate loading for refractory status epilepticus in children. Epilepsia. 2006;47:1070-1071.
103. Atefy R, Tettenborn B. Nonconvulsive status epilepticus on treatment with levetiracetam. Epilepsy Behav. 2005;6:613-616.
104. Patel NC, Landan IR, Levin J, et al. The use of levetiracetam in refractory status epilepticus. Seizure. 2006;15:137-141.
105. Rossetti AO, Bromfield EB. Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav. 2006;8:651-654.
106. Herranz JL, Argumosa A. [Characteristics of drugs used in the treatment of acute convulsions and convulsive status]. Rev Neurol. 2000;31:757-762.
107. Claassen J, Lokin JK, Fitzsimmons BF, et al. Predictors of functional disability and mortality after status epilepticus. Neurology. 2002;58:139-142.
108. Logroscino G, Hesdorffer DC, Cascino G, et al. Short-term mortality after a first episode of status epilepticus. Epilepsia. 1997;38:1344-1349.
109. Maytal J, Shinnar S, Moshe SL, et al. Low morbidity and mortality of status epilepticus in children. Pediatrics. 1989;83:323-331.
110. Meldrum BS, Brierley JB. Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. Arch Neurol. 1973;28:10-17.
111. Manno EM, Pfeifer EA, Cascino GD, et al. Cardiac pathology in status epilepticus. Ann Neurol. 2005;58:954-957.
112. Dodrill CB, Wilensky AJ. Intellectual impairment as an outcome of status epilepticus. Neurology. 1990;40(5 suppl. 2):23-27.
113. Lowenstein DH, Aminoff MJ. Clinical and EEG features of status epilepticus in comatose patients. Neurology. 1992;42:100-104.